Molecular pathogenesis of the myeloproliferative neoplasms

by Graeme Greenfield, Mary Frances McMullin, Ken Mills
Published 2021-06-01

The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms

by Graeme Greenfield, Suzanne McPherson, Ken Mills, Mary Frances McMullin
Published 2018-12-01

Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study

by John Busby, Ken Mills, Shu-Dong Zhang, Fabio Giuseppe Liberante, Chris R. Cardwell
Published 2018-01-01

An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mapping

by Gayathri Thillaiyampalam, Fabio Liberante, Liam Murray, Chris Cardwell, Ken Mills, Shu-Dong Zhang
Published 2017-12-01

Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms

by Graeme Greenfield, Suzanne McPherson, James Smith, Adam Mead, Claire Harrison, Ken Mills, Mary Frances McMullin
Published 2020-09-01

The Northern Ireland Biobank: A Cancer Focused Repository of Science

by Claire Lewis, Stephen McQuaid, Priscilla Clark, Paul Murray, Tracey McGuigan, Christine Greene, Bronagh Coulter, Ken Mills, Jacqueline James
Published 2018-09-01

Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study

by Blánaid M. Hicks, John Busby, Ken Mills, Francis A. O’Neil, Stuart A. McIntosh, Shu-Dong Zhang, Fabio Giuseppe Liberante, Chris R. Cardwell
Published 2020-08-01

Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysis.

by Clare M McCourt, Darragh G McArt, Ken Mills, Mark A Catherwood, Perry Maxwell, David J Waugh, Peter Hamilton, Joe M O'Sullivan, Manuel Salto-Tellez
Published 2013-01-01

Characterisation of genome-wide PLZF/RARA target genes.

by Salvatore Spicuglia, Christelle Vincent-Fabert, Touati Benoukraf, Guillaume Tibéri, Andrew J Saurin, Joaquin Zacarias-Cabeza, David Grimwade, Ken Mills, Boris Calmels, François Bertucci, Michael Sieweke, Pierre Ferrier, Estelle Duprez
Published 2011-01-01

GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways

by Laura Guerenne, Stéphanie Beurlet, Mohamed Said, Petra Gorombei, Carole Le Pogam, Fabien Guidez, Pierre de la Grange, Nader Omidvar, Valérie Vanneaux, Ken Mills, Ghulam J Mufti, Laure Sarda-Mantel, Maria Elena Noguera, Marika Pla, Pierre Fenaux, Rose Ann Padua, Christine Chomienne, Patricia Krief
Published 2016-01-01